Much Ado about Adenosine: Adenosine Synthesis and Function in Regulatory T Cell Biology
- 15 August 2010
- journal article
- review article
- Published by The American Association of Immunologists
- Vol. 185 (4), 1993-1998
- https://doi.org/10.4049/jimmunol.1000108
Abstract
Recent studies have reported that adenosine is a significant mediator of regulatory T cell (Treg) function. Indeed, activation of the adenosine receptor subtypes expressed by a broad range of immune and inflammatory cells attenuates inflammation in several disease models. This anti-inflammatory response is associated with an increase in intracellular cAMP that inhibits cytokine responses of many immune/inflammatory cells, including T cells and APCs. Thus, adenosine produced by Tregs can provide a paracrine feedback that shapes the host response following an immunologic provocation. This review discusses the evidence that adenosine is an integral part of Treg biology and presents some of the mechanisms that may account for its contribution to the resolution of inflammation and the regulation of the immune/inflammatory cell phenotype.Keywords
This publication has 89 references indexed in Scilit:
- A‐kinase anchoring proteins: From protein complexes to physiology and diseaseIUBMB Life, 2009
- A2A adenosine receptor (AR) activation inhibits pro-inflammatory cytokine production by human CD4+ helper T cells and regulates Helicobacter-induced gastritis and bacterial persistenceMucosal Immunology, 2009
- miR‐142‐3p restricts cAMP production in CD4+CD25− T cells and CD4+CD25+ TREG cells by targeting AC9 mRNAEMBO Reports, 2008
- IL-4 inhibits TGF-β-induced Foxp3+ T cells and, together with TGF-β, generates IL-9+ IL-10+ Foxp3− effector T cellsNature Immunology, 2008
- A2B Adenosine Receptor Gene Deletion Attenuates Murine ColitisGastroenterology, 2008
- Adenosine receptors: therapeutic aspects for inflammatory and immune diseasesNature Reviews Drug Discovery, 2008
- Foxp3+natural regulatory T cells preferentially form aggregates on dendritic cellsin vitroand actively inhibit their maturationProceedings of the National Academy of Sciences of the United States of America, 2008
- Signaling through cAMP and cAMP-dependent protein kinase: Diverse strategies for drug designBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2007
- From ‘Hellstrom Paradox–to anti-adenosinergic cancer immunotherapyPurinergic Signalling, 2007
- A2A adenosine receptor protects tumors from antitumor T cellsProceedings of the National Academy of Sciences, 2006